Sign In
Buy GILD
$125.16
+0.110 (+0.0880%)
At Close: Jun 24, 2026
Gilead Beats Earnings Expectations After Rocky Quarter
05:49pm, Thursday, 25'th Apr 2024
The biotech reported a loss for the quarter of $1.32 per share, better than the FactSet consensus estimate of a loss of $1.49 per share.
Gilead Notches A Quarterly Beat On The Back Of Its Covid Drug, Again
04:40pm, Thursday, 25'th Apr 2024
Gilead beat first-quarter calls, but it came on the back of Covid drug Veklury. And Gilead stock jumped in late trades Thursday.
Gilead's quarterly loss is narrower than expected
04:28pm, Thursday, 25'th Apr 2024
Gilead Sciences Inc.'s stock rose 0.8% in after-hours trading Thursday, after the drug company's adjusted first-quarter profit was narrower than expected.
What's in Store for These 5 Pharma Bigwigs in Q1 Earnings?
10:21am, Wednesday, 24'th Apr 2024
Let's look at five biotech/drug companies, MRK, SNY, BMY, GILD and ABBV, slated to release their first quarter 2024 earnings results this week.
Gilead (GILD) Gears Up to Report Q1 Earnings: What to Expect?
03:01pm, Monday, 22'nd Apr 2024
Investors' focus is likely to be on Gilead's (GILD) HIV franchise performance and oncology sales when the company reports first-quarter 2024 results.
Undervalued Icons: 3 Household Names Trading at Steep Discounts
02:19pm, Monday, 22'nd Apr 2024
Among Wall Street stocks, some of the best opportunities can be found in reliable companies trading at a discount. With such undervalued stocks, investors get a strong foundation for their portfolio a
Gilead Sciences (GILD) Increases Despite Market Slip: Here's What You Need to Know
06:51pm, Friday, 19'th Apr 2024
Gilead Sciences (GILD) closed the most recent trading day at $66.76, moving +0.91% from the previous trading session.
Gilead Sciences (GILD) Sees a More Significant Dip Than Broader Market: Some Facts to Know
07:06pm, Thursday, 18'th Apr 2024
Gilead Sciences (GILD) closed at $66.16 in the latest trading session, marking a -1.15% move from the prior day.
Analysts Estimate Gilead Sciences (GILD) to Report a Decline in Earnings: What to Look Out for
11:08am, Thursday, 18'th Apr 2024
Gilead (GILD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Gilead Sciences, Inc. (GILD) is Attracting Investor Attention: Here is What You Should Know
10:01am, Tuesday, 16'th Apr 2024
Recently, Zacks.com users have been paying close attention to Gilead (GILD). This makes it worthwhile to examine what the stock has in store.
Gilead Sciences (GILD) Exceeds Market Returns: Some Facts to Consider
07:21pm, Tuesday, 09'th Apr 2024
In the most recent trading session, Gilead Sciences (GILD) closed at $69.94, indicating a +0.75% shift from the previous trading day.
3 Stocks at 52-Week Lows Poised for a Powerful Rebound
02:40pm, Tuesday, 09'th Apr 2024
With strong market performance in recent periods, finding stocks priced at a discount can be challenging. However, examining stocks at 52-week lows may identify equities valued below their potential.
Gilead Sciences to Release First Quarter 2024 Financial Results on Thursday, April 25, 2024
04:05pm, Monday, 08'th Apr 2024
FOSTER CITY, Calif.--(BUSINESS WIRE)-- #Earnings--Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its first quarter 2024 financial results and guidance will be released on Thursday, April 25
Got $5,000? These 3 High-Yielding Dividend Stocks Are Trading Near Their 52-Week Lows
08:30am, Friday, 05'th Apr 2024
Starbucks, BCE, and Gilead Sciences pay dividends that yield well above the S&P 500 average. These companies all have strong businesses that can make for ideal long-term investments.
Gilead Sciences, Inc. (GILD) Is a Trending Stock: Facts to Know Before Betting on It
10:00am, Wednesday, 03'rd Apr 2024
Gilead (GILD) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
